Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Dulaglutide (Primary) ; Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DUET-beta study
- 11 Jun 2019 Results of the DUET-Beta Extension Study (n=48) presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes.
- 26 Jun 2018 Primary endpoint has not been met. (Comparing the two groups of change in beta-cell function over the 24-week treatment period, measured using the disposition index.) as per results presented at the 78th Annual Scientific Sessions of the American Diabetes Association